Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran.
Mehran AkbariMojtaba DidehdarMohsen NazariDavood AzadiPublished in: Future virology (2021)
Aim: We report two cases of pediatric patients diagnosed and treated for pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS) symptoms. Materials & methods: Two previously healthy 3- and 4-year-old boys were referred to the hospital after 5 days of 39°C fever, with symptoms such as erythema multiform in the lower extremities, irritability, refusal to eat, restlessness, lymphadenopathy, conjunctivitis and abnormal echocardiography. Results: After 8 days of hospitalization, the patients showed normal laboratory tests, improvement of clinical condition and were discharged from the hospital. Conclusion: This study raised several issues for physicians about SARS-CoV-2, its complications, diagnosis and treatment. Based on our results, pediatrics with PIMS-TS should be first screened for SARS-CoV-2, then treated with a combination of antivirals, anti-inflammatories, antibiotics and intravenous immune globulin.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- newly diagnosed
- end stage renal disease
- sleep quality
- oxidative stress
- primary care
- ejection fraction
- prognostic factors
- peritoneal dialysis
- case report
- computed tomography
- heart failure
- pulmonary hypertension
- risk factors
- patient reported outcomes
- depressive symptoms
- young adults
- physical activity
- atrial fibrillation
- patient reported
- soft tissue
- electronic health record